Black Diamond Therapeutics, Inc. (BDTX)

Last Year

01-May-23 -- 30-Apr-24

Time Period:

$24.23M Net Amount

Buy:	$24.23M	$5.00 - $5.49
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

2

+1

0

+2

3

+3

Two Year Chart

01-May-22 -- 30-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
28-Jun-23 4:02 PM View:	27-Jun-23 Private Sale (Planned) ($167.50K)	Epstein David M. See Remarks Director		Black Diamond Therapeutics, Inc. - BDTX	(3%) 961.57K to 936.57K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 9:00 PM View:	15-Mar-24 Grant $14.37K	Behbahani Ali Director		Black Diamond Therapeutics, Inc. - BDTX	29% 3.49M to 4.5M	$5.00M 29%	0	$5.00	--	Show Txns Hide Txns

03-Apr-24 8:49 PM View:	15-Mar-24 Grant $14.77K	Dixon Wendy L Director		Black Diamond Therapeutics, Inc. - BDTX	37% 27.77K to 38.05K	0	0	--	--	Show Txns Hide Txns

19-Oct-23 3:08 PM View:	17-Oct-23 Private Purchase $934.08K	Biotech Growth N V 10% Owner		Black Diamond Therapeutics, Inc. - BDTX	58% 5.38M to 8.52M	$14.56M 51%	0	$5.00 - $5.49	--	Show Txns Hide Txns

07-Jul-23 4:30 PM View:	05-Jul-23 Market Purchase $4.68M	Ra Capital Management, LLC Director		Black Diamond Therapeutics, Inc. - BDTX	36% 2.59M to 3.53M	$4.68M 36%	0	$5.00	--	Show Txns Hide Txns

18-Sep-23 5:26 PM View:	15-Sep-23 Grant $18.75K	Velleca Mark A. PRESIDENT & CEO Director		Black Diamond Therapeutics, Inc. - BDTX	13% 41.31K to 46.52K	0	0	--	--	Show Txns Hide Txns